Patents by Inventor David Vindrieux

David Vindrieux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCL5 AS A MARKER OF HORMONE ESCAPE IN PROSTATE CANCER
    Publication number: 20150125863
    Abstract: The invention relates to the use of CXCL5 as a marker for assessing hormone escape in prostate cancer cells. The invention further provides diagnostic methods and kits for assessing hormone escape in prostate cancer cells, and CXCL5 antagonists for use in the treatment or prevention of prostate cancer and/or hormone escape in prostate cancer.
    Type: Application
    Filed: January 14, 2015
    Publication date: May 7, 2015
    Inventors: Gwendal LAZENNEC, David VINDRIEUX, Brigitte MADLY
  • PLA2R1 AS ANTI-TUMORAL COMPOUND AND AS BIOMARKER FOR THE DETECTION OF CANCER
    Publication number: 20140155470
    Abstract: Compositions comprising a polynucleotide of human PLA2R1, a polypeptide of human PLA2R1 or an extracellular fragment of human PLA2R1 for use in the treatment of cancer in particular breast cancer, pancreatic cancer, colorectal cancer, kidney cancer and melanoma.
    Type: Application
    Filed: July 6, 2012
    Publication date: June 5, 2014
    Inventors: David Bernard, Arnaud Augert, Gerard Lambeau, Christophe Girard, David Vindrieux
  • CXCL5 AS A MARKER OF HORMONE ESCAPE IN PROSTATE CANCER
    Publication number: 20130101600
    Abstract: The invention relates to the use of CXCL5 as a marker for assessing hormone escape in prostate cancer cells. The invention further provides diagnostic methods and kits for assessing hormone escape in prostate cancer cells, and CXCL5 antagonists for use in the treatment or prevention of prostate cancer and/or hormone escape in prostate cancer.
    Type: Application
    Filed: April 19, 2011
    Publication date: April 25, 2013
    Inventors: Gwendal Lazennec, David Vindrieux, Brigitte Madly